We propose that UV exposure contributes to the anatomical localization and selective pressures faced by clonal pDCs or precursors during the early stages of BPDCN development in the skin, and may explain the high fraction of TET2 alterations observed in this malignancy. This evidence concerns the gene TET2 and CD4+/CD56+ hematodermic neoplasm.